U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07568626) titled 'Factors for Prolonged Hospital Stays in Patients Undergoing ERCP' on April 28.
Brief Summary: Endoscopic retrograde cholangiopancreatography (ERCP) is a crucial minimally invasive technique for the diagnosis and treatment of biliary and pancreatic diseases. However, it remains technically demanding and carries a postoperative adverse event (AE) rate exceeding 10% (e.g., pancreatitis, bleeding, and perforation), which subsequently leads to prolonged length of stay (LOS) and increased healthcare costs. With the rapid acceleration of population aging, the clinical demand for ERCP among the elderly has surged. Although ERCP is generally c...